Monsanto Co. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co.

MTC 2.160

+1.9%

Nov 19 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: TheSlowLane who wrote (479)	11/9/1998 8:17:00 PM
From: Anthony Wong	Read Replies (1) of 2539

FDA ARTHRITIS ADVISORY COMMITTEE meeting: DATE AND TIME: Dec. 1, and 2, 8 a.m. LOCATION: Town Center Hotel, The Maryland Ballroom, 8727 Colesville Rd., Silver Spring, MD. CONTACT: Kathleen Reedy or LaNise Giles, Center for Drug Evaluation and Research, 301-827-7001. The Committee will discuss Celebrex (celecoxib, Searle) for the treatment of acute or chronic signs and symptoms of osteoarthritis and rheumatoid arthritis and the management of pain. On Dec. 2, from 8 a.m. to 4 p.m. the meeting will be closed to permit review of confidential information. fda.gov

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next